The monkeypox virus, which has created a new fear of epidemics in the world after the coronavirus, has been seen in 16 different countries so far. While it was observed that the cases continued to increase especially in Western Europe, US President Joe Biden’s statement “Everyone should be worried” also increased the attention to the virus.
Today, there has been an extremely important development in the United States regarding the monkeypox virus. The US Centers for Disease Control and Prevention (CDC) announced that the monkeypox vaccine in the country’s Strategic National Stockpile will become available against the monkeypox virus, which is increasingly seen in the country.
Jynneos vaccine to be used in high-risk patients
CDC’s Dr. Jennifer McQuiston shared, “I can report that there is a demand for the release of the Jynneos vaccine from the National Stockpile for high-risk contacts of some of the first patients, it is currently actively happening.” used the expressions. McQuiston explained that the United States also has a good stock of vaccines as it prepares for the possibility of needing doses for smallpox.
The aforementioned Jynneos vaccine was licensed in the USA to prevent smallpox and especially monkeypox. According to the information quoted by McQuiston, the country currently has more than 1,000 doses and the company has started to provide more doses to the USA. ACAM2000, another licensed vaccine that can be used to prevent monkeypox, has been announced to have more than 100 million doses in the country.
18619
